2007 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
David A. Lewis mainly focuses on Neuroscience, Prefrontal cortex, Schizophrenia, Psychosis and Neuron. As part of his studies on Neuroscience, David A. Lewis frequently links adjacent subjects like Neurotransmission. His study in Prefrontal cortex is interdisciplinary in nature, drawing from both Glutamate decarboxylase, Endocrinology, Central nervous system, Internal medicine and In situ hybridization.
The study incorporates disciplines such as Working memory, Cognition, Microarray, Biological neural network and Neuroplasticity in addition to Schizophrenia. His Psychosis research is multidisciplinary, relying on both Postmortem studies, Cannabinoid and Thalamus. His studies in Neuron integrate themes in fields like Nerve net and GABAergic.
David A. Lewis mostly deals with Neuroscience, Prefrontal cortex, Schizophrenia, Internal medicine and Endocrinology. His study ties his expertise on Neurotransmission together with the subject of Neuroscience. His work investigates the relationship between Prefrontal cortex and topics such as Central nervous system that intersect with problems in Dopamine.
His Schizophrenia study incorporates themes from Dendritic spine, Bipolar disorder, Cognition and Auditory cortex. He has included themes like Major depressive disorder and Depression in his Internal medicine study. His Endocrinology research includes themes of Gene expression and In situ hybridization.
David A. Lewis mainly investigates Neuroscience, Schizophrenia, Dorsolateral prefrontal cortex, Working memory and Prefrontal cortex. His research brings together the fields of Neurotransmission and Neuroscience. His study explores the link between Schizophrenia and topics such as Bipolar disorder that cross with problems in Major depressive disorder, Cell type specific and Schizoaffective disorder.
His Dorsolateral prefrontal cortex study integrates concerns from other disciplines, such as Endocrinology, Glutamate receptor, Postmortem studies, Internal medicine and Biological neural network. His Working memory study incorporates themes from Schizophrenia and Expression. The Prefrontal cortex study combines topics in areas such as Receptor and GABAergic.
David A. Lewis mainly focuses on Neuroscience, Schizophrenia, Dorsolateral prefrontal cortex, Internal medicine and Parvalbumin. His is doing research in Excitatory postsynaptic potential, Working memory, Inhibitory postsynaptic potential, Prefrontal cortex and Neuron, both of which are found in Neuroscience. His Prefrontal cortex research focuses on GABAergic and how it connects with Postmortem studies, Glutamate decarboxylase, Calbindin and Calretinin.
The study incorporates disciplines such as Genome-wide association study, Quantitative trait locus, Expression quantitative trait loci, Genotyping and Colocalization in addition to Schizophrenia. The Dorsolateral prefrontal cortex study which covers Visual cortex that intersects with gamma-Aminobutyric acid, Cerebral cortex and Vasoactive intestinal peptide. His Internal medicine research includes elements of Major depressive disorder, Endocrinology, Small hairpin RNA and Messenger RNA.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cortical inhibitory neurons and schizophrenia
David A. Lewis;Takanori Hashimoto;David W. Volk.
Nature Reviews Neuroscience (2005)
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.
Leisa A. Glantz;David A. Lewis.
Archives of General Psychiatry (2000)
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex
Giorgio A. Ascoli;Lidia Alonso-Nanclares;Stewart A. Anderson;German Barrionuevo.
Nature Reviews Neuroscience (2008)
Schizophrenia as a Disorder of Neurodevelopment
David A Lewis;Pat Levitt.
Annual Review of Neuroscience (2002)
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
Károly Mirnics;Frank A. Middleton;Adriana Marquez;David A. Lewis.
Catching up on schizophrenia: natural history and neurobiology
David A Lewis;Jeffrey A Lieberman.
Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
Takanori Hashimoto;David W. Volk;Stephen M. Eggan;Karoly Mirnics.
The Journal of Neuroscience (2003)
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
David A. Lewis;Allison A. Curley;Jill R. Glausier;David W. Volk.
Trends in Neurosciences (2012)
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Ranjan Dutta;Jennifer McDonough;Xinghua Yin;John Peterson.
Annals of Neurology (2006)
New insights into the classification and nomenclature of cortical GABAergic interneurons
Javier DeFelipe;Pedro L. López-Cruz;Ruth Benavides-Piccione;Ruth Benavides-Piccione;Concha Bielza.
Nature Reviews Neuroscience (2013)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: